M&A Deal Summary

Cencora Acquires Network for Medical Communication and Research

On February 9, 2006, Cencora acquired life science company Network for Medical Communication and Research from Evolve Capital and American Capital for 90M USD

Acquisition Highlights
  • This is Cencora’s 1st transaction in the Life Science sector.
  • This is Cencora’s 12th largest (disclosed) transaction.
  • This is Cencora’s 3rd transaction in the United States.
  • This is Cencora’s 1st transaction in Georgia.

M&A Deal Summary
Date 2006-02-09
Target Network for Medical Communication and Research
Sector Life Science
Buyer(s) Cencora
Sellers(s) Evolve Capital
American Capital
Deal Type Add-on Acquisition
Deal Value 90M USD

Target

Network for Medical Communication and Research

Atlanta, Georgia, United States
Network for Medical Communication and Research LLC is a provider of quantitative and qualitative behavioral research services. It specializes in obtaining and analyzing quantitative and qualitative information on changing fields of hematology and oncology research and practice.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cencora

Conshohocken, Pennsylvania, United States
Category Company
Founded 2001
Sector Distribution
Employees46,000
Revenue 262.2B USD (2023)
DESCRIPTION

Cencora is a pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and care. Cencora was founded in 2001 and is based in Conshohocken, Pennsylvania.

DEAL STATS #
Overall 3 of 15
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 2 of 12
State (Georgia) 1 of 1
Country (United States) 3 of 14
Year (2006) 1 of 1
Size (of disclosed) 12 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-17 U.S Bioservices

Frisco, Texas, United States

U.S. Bioservices Corporation provides healthcare support services for pharmaceutical manufacturers, physicians, payers, and patients. The company partners with these related parties to deliver expert care to patients with complex and chronic medical conditions nationwide. U.S. Bioservices is no longer a J.H. Whitney portfolio company.

Buy $160M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-04-03 Xcenda

Palm Harbor, Florida, United States

Xcenda LLC a strategic consulting firm with 20 years of experience applying expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy to support global pharmaceutical companies, as well as emerging pre-commercialization phase firms.

Buy $25M

Seller(S) 2

SELLER

Evolve Capital

Dallas, Texas, United States

Investor Investor Investor Investor

Category Private Equity Firm
Founded 2005
Size Small
Type Sector Agnostic
DESCRIPTION

Evolve Capital is a private equity firm focused exclusively on recapitalization investments in growth-oriented service based businesses. Evolve looks companies that are asset light, growing rapidly, and potentially operate in a regulated environment. Target companies typically have trailing EBITDA of $2 to $4 million and are located in the US. Evolve Capital was formed in 2005 and is based in Dallas, Texas.

DEAL STATS #
Overall 3 of 18
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 6
State (Georgia) 1 of 1
Country (United States) 3 of 18
Year (2006) 1 of 1
Size (of disclosed) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-09-01 Texas Home Health

Dallas, Tennessee, United States

Guardian Home Care Holdings is a provider of home healthcare and hospice services with over 40 offices in Texas, Georgia and Tennessee.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-04-01 Indigo BioAutomation

Carmel, Indiana, United States

Indigo BioAutomation is a provider of technology to scientific research organizations allowing them to manage and interchange critical research data. Indigo BioAutomation was founded in 2006 and is based in Carmel, Indiana.

Buy -
SELLER

American Capital

Category Private Equity Firm
Founded 1997
PE ASSETS 22.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

American Capital was a publicly traded buyout and mezzanine investment firm. American Capital invested in buyouts, growth capital financings, acquistion financings, and recapitalizations. The Firm looked to finance businesses with at least $4 million in EBITDA and valued between $20 and $500 million. American Capital ws a generalist firm with broad interest in traditional industries such as manufacturing, distribution, and services. American Capital's European investment affiliate is European Capital. European Capital looked to invest $10 to $600 million of equity, mezzanine, and/or senior debt in similar opportunities across Europe. American Capital was formed in 1997 and in January 2017, merged with Ares Capital Management.

DEAL STATS #
Overall 37 of 194
Sector (Life Science) 2 of 6
Type (Add-on Acquisition) 16 of 87
State (Georgia) 4 of 10
Country (United States) 36 of 186
Year (2006) 6 of 26
Size (of disclosed) 44 of 56
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-07 ASAlliances Biofuels

Dallas, Texas, United States

ASAlliances Biofuels LLC, an entity developed by Americas Strategic Alliances LLC to construct three large-scale ethanol production facilities.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-02-23 Meadows of Wickenburg

Wickenburg, Arizona, United States

Meadows of Wickenburg is a premier multi-disorder inpatient facility specializing in the treatment of a broad range of addictions. The Meadows is a multi-disorder facility specializing in the treatment of trauma and addictions. The Meadows' clinical experts reach beyond single-level treatment of addictions, behavioral disorders and psychological conditions to diagnose and treat the underlying problems. Meadows of Wickenburg was founded in 1976 and is based in Wickenburg, Arizona.

Buy $79M
Mergr

Product

Company

Legal